3309 — C-Mer Eye Care Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$3.54bn
- HK$3.49bn
- HK$1.92bn
- 77
- 27
- 32
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 576 | 700 | 1,113 | 1,732 | 1,924 |
Cost of Revenue | |||||
Gross Profit | 191 | 194 | 358 | 448 | 619 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 515 | 691 | 1,088 | 1,768 | 1,805 |
Operating Profit | 60.9 | 8.08 | 24.7 | -36.5 | 119 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 53.2 | 2.5 | 26.9 | -11.2 | 124 |
Provision for Income Taxes | |||||
Net Income After Taxes | 39.1 | -8.41 | 16.2 | -46.2 | 86.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 41.4 | -6.25 | 21.9 | -21.9 | 62 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 41.4 | -6.25 | 21.9 | -21.9 | 62 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.039 | -0.007 | 0.021 | -0.018 | 0.052 |
Dividends per Share |